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Background: Helicobacter pylori causes acute and chronic gastric inflammation induced by proinflammatory
cytokines and chemokines secreted by cells of the gastric mucosa, including gastric epithelial cells. Previous studies
have demonstrated that the bacterial arginase, RocF, is involved in inhibiting T cell proliferation and CD3ζ
expression, suggesting that arginase could be involved in a more general dampening of the immune response,
perhaps by down-regulation of certain pro-inflammatory mediators.
Results: Global transcriptome analysis was performed on AGS gastric epithelial cells infected for 16 hours with a wild
type Helicobacter pylori strain 26695, an arginase mutant (rocF-) or a rocF+ complemented strain. H. pylori infection
triggered altered host gene expression in genes involved in cell movement, death/growth/proliferation, and cellular
function and maintenance. While the wild type strain stimulates host inflammatory pathways, the rocF- mutant induced
significantly more expression of IL-8. The results of the microarray were verified using real-time PCR, and the differential
levels of protein expression were confirmed by ELISA and Bioplex analysis. MIP-1B was also significantly secreted by
AGS cells after H. pylori rocF- mutant infection, as determined by Bioplex. Even though not explored in this manuscript,
the impact that the results presented here may have on the development of gastritis, warrant further research to
understand the underlying mechanisms of the relationship between H. pylori RocF and IL-8 induction.
Conclusions: We conclude that H. pylori arginase modulates multiple host signaling and metabolic pathways of
infected gastric epithelial cells. Arginase may play a critical role in anti-inflammatory host responses that could
contribute to the ability of H. pylori to establish chronic infections.
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Helicobacter pylori (H. pylori) causes a spectrum of gas-
tric diseases ranging from mild to severe gastritis and
peptic ulcers to gastric cancer [1]. During early stages of
infection, H. pylori adheres to the gastric epithelial cells
in the gastric pit, leading to induction of chemokines
and cytokines. These proinflammatory mediators induce
the infiltration of neutrophils and lymphocytes. Despite
this immune response, the infection is not cleared [2] and
patients can remain chronically-infected for decades if not* Correspondence: dmcgee@lsuhsc.edu; jzabal@lsuhsc.edu
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reproduction in any medium, provided the ortreated. This chronicity suggests the bacterium has evolved
strategies to persist in the gastric mucosa despite strong im-
mune responses, indicating that H. pylori, in addition to in-
ducing factors to promote inflammation, may also have
factors to dampen the host immune responses.
Several H. pylori factors have been associated with
virulence including the vacuolating cytotoxin (VacA),
the product of the cytotoxin-associated gene (CagA) and
the H. pylori urease [3-9]. However, the mechanisms of
pathogenesis caused by other H. pylori factors are only
beginning to be understood.
H. pylori arginase [EC 3.5.31, RocF] hydrolyzes argin-
ine to ornithine and urea, the latter of which may serve
as an endogenous substrate for the powerful H. pylori
urease enzyme, to generate carbon dioxide and ammo-
nia. The H. pylori RocF is associated with the inner cell. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mammalian arginases which use manganese [10-12].
Interestingly, arginase activity has an acidic pH optimum
and increases the resistance of H. pylori to acid in an
arginine-dependent fashion [11]. Moreover, since the
rocF- mutant is unable to hydrolyze and consume argin-
ine [13,14], extracellular arginine levels are readily avail-
able for macrophages to produce nitric oxide (NO) to
kill the bacteria [15].
Both in a tissue culture system and from peripheral
blood from human volunteers, it was shown that, in
contrast with wild type H. pylori, the rocF- mutant pro-
motes T cell proliferation and expression of the import-
ant T cell surface signaling molecule, CD3ζ [16]. Thus,
arginase is involved in dampening the innate (acid,
NO) and adaptive (T cell) immune responses, but the
specific mechanisms are not entirely understood. H.
pylori arginase in gastric epithelial cell response is un-
known. We therefore sought to determine the impact
of H. pylori rocF- on epithelial cell transcription and
cytokine/chemokine profiles using Illumina gene chip
analysis, real-time PCR, ELISA and Bioplex analysis.
Results
Differential gene expression profile between H. pylori
26695 wild type and rocF- mutant strains
Gastric adenocarcinoma epithelial cell line AGS has been
extensively studied and reviewed as a valid in vitro model
for H. pylori interactions [17]. H. pylori arginase, encoded
by rocF, plays an important role in both innate and adaptive
immunity [15,16], but nothing is known about the gastric
epithelial response. This question was addressed by tran-
scriptome analysis of AGS cells infected by wild type, the
rocF- mutant, and rocF+ complemented H. pylori strains.
The log10 transformed data of the net intensity signal,
using non-infected cells (NS) as reference, was used to gen-
erate a heat-map of gene expression profiles of the different
H. pylori treatments in AGS cells. As seen in Figure 1A, the
expression profile of both WTand the complemented rocF+
was very similar. In contrast, the gene profile obtained in
response to the infection with the H. pylori arginase mu-
tant (rocF-) was completely different to the profiles gener-
ated by the other two strains as evidenced by the
localization of the rocF- strain in a separate branch of the
dendrogram. Interestingly, a set of genes associated with
pro-apoptotic and anti-apoptotic pathways were differen-
tially expressed in the rocF- mutant as compared to the
wild type or rocF+ strains (Figure 1A). In addition, infection
with the rocF- mutant affected the expression of more
genes than WT while the number of genes was similar in
both number and intensity between the WT and the com-
plemented bacteria. Using Metacore software analysis
(Thomson Reuters, Philadelphia, PA), we found that while
262 genes were common to the infection with all threeH. pylori strains, infection with rocF- resulted in modula-
tion of 2,563 genes of which 1,718 were uniquely induced
by this strain (Figure 1B). In contrast, compared to rocF-,
infection with either the WT or the rocF+ induced a lower
number of genes (868 and 1153, respectively) of which
only 23 were uniquely induced by the WT strain and 308
by the rocF+ (Figure 1B). All three combined shaded areas
represent 583 “similar” genes, those that are not “unique”
to each treatment, or “common” to the three conditions,
but are similar to any pair of treatments. To understand
how these genes interact we generated networks and path-
ways maps using the MetaCore software. The network
with the maximum G-score (127.02, based on the number
of interactions), with a p=2.1 x 10-16 (RelA, NFκB, c-IAP2,
NFKBIA, MUC1) was assembled and showed a central
core formed by the NFκB family. This central core was fur-
ther expanded to highlight the most relevant genes (those
with stronger associations) and this revealed a set of genes
associated with inflammatory responses, including IL-8,
NFκB, and STATs (Figure 2A). It is noteworthy that, based
on the network, IL-8 is one of the most modulated genes
in this central core, with interactions with several other
genes, including NFKB, NFKB1, STAT3, and the histone
acetyl-transferase p300 (EP300), the latter functioning as
an IL-8 activator either directly or indirectly through the
activation of other genes involved in IL-8 transcription
(Figure 2A). Figure 2B shows the similarity of the replicates
(numbered in parenthesis) using the net intensity of the
transcripts shown in Figure 2A. As observed, the dendro-
gram pattern shows that WT and rocF+H. pylori are simi-
lar as they mix together, while the rocF- segregates in a
separate branch of the dendrogram, showing different pat-
terns of expression. Pathway maps analysis revealed the
importance of the immune system in the H. pylori infec-
tion. The map showing the highest significance was asso-
ciated with immune response (p value 1.018 x 10-5) and
involved many of the genes present in the network, includ-
ing IL6, IL-8, NFKB, AP-1, JUN, and IL1B (data not
shown). Even though IL-8 was the most modulated gene
from our microarray analysis, it was not the only one.
Table 1 shows the raw and the net expression signals of
the 10 most up- and the 10 most down-regulated genes in
AGS cells infected with the different strains of H. pylori.
Based on the direct analysis of the gene list, and those
obtained from networks and pathways analysis, and very
especially on the role of IL-8 in the induction of inflamma-
tory responses, we focused our efforts on confirming the
effects of the infection on IL-8 production.
The rocF- H. pylori mutant induces more IL-8 in gastric
epithelial cells than wild type H. pylori
We used real-time PCR to confirm the expression of the
genes shown in Figure 2. For this, we obtained the fold
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Figure 1 Differential gene expression profiles of AGS gastric epithelial cells infected with WT, rocF- and the rocF+ complemented H.
pylori strains. A. Representative portion of the Log10 ratio between the net expression values between the infected and the non-infected cells,
as described in Materials and Methods. The analysis was done using four replicates of each treatment. The marked areas above the heat map
show genes associated with different cellular functions. B. Venn diagram showing the number of genes affected (up- and down-regulated) by
the infection of AGS cells with the WT, rocF-, or rocF+ strains of H. pylori. The green number (262) indicates the number of genes that are
common to all treatments; the black numbers indicate unique genes in each treatment; the total shaded area represent 583 genes that are
neither common nor unique (similar genes).
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ternal calibrator. The fold induction at 0 h was sub-
tracted and the signal obtained in the NS used to
determine the ratio of the induction of each gene in WT,
rocF- and rocF+ infected AGS cells. As seen in Figure 3,
infection with the H. pylori rocF- mutant induced 40 and
23 times more IL-8 than the H. pylori WT or the rocF+
complemented strain, respectively (p <0.0001). No signifi-
cant difference was found in the fold induction of the
other genes (Figure 3). The data suggest that the H. pylori
arginase may act as an important modulator of inflamma-
tory responses through the control of IL-8 transcription in
gastric epithelial cells.
Due to the biological importance of IL-8 and because
the microarray suggested wider and stronger cytokine
inductions by H. pylori 26695 rocF- mutant than the wild
type and the complemented bacteria at the transcriptio-
nal level, Bio-Plex analysis was further pursued to simul-
taneously examine 27 different human cytokines andchemokines (Human Cytokine Assay Group 1 platform).
Fourteen cytokines and growth factors were induced
by at least one of the H. pylori strains. IL-8 was the
most abundantly expressed cytokine/chemokine, espe-
cially by the AGS cells infected with the H. pylori
rocF- mutant strain (1068± 243.8 pg/ml) as compared
to the WT (428± 13.4) or the complemented isogenic
strain (529± 73.1) (Figure 4A). From the Bio-plex analysis
it was evident that, in addition to IL-8, the rocF- bacteria
also induced higher levels of MIP-1B, as compared with
the other strains (Figure 4B). To confirm the Bio-Plex
results we checked the levels of IL-8 by ELISA and found
that, indeed, the H. pylori rocF- mutant induced more
than two times more IL-8 in AGS cells, as compared to
the WT or the rocF+ complemented bacteria (Figure 5).
Discussion
While it is well-known that H. pylori induces inflamma-
tion, this inflammatory response is insufficient to clear
Figure 2 Network interactions in AGS cells infected with H. pylori. A. Expanded central node of a network (RelA (p65), NFkB, c-IAP2, NFkBIA,
and MUC1) generated using the net gene expression values of the different H. pylori infections of the AGS cells. Green arrow=positive regulation;
green icons represent receptor ligands (IL-8, VEGFA); red icons represent transcription factors (NFKB1, STAT3); yellow icon represent generic enzyme
(p300). Thicker arrows indicate stronger association. B. Heatmap showing the similarity of the different replicates, using the Log10 ratio of the
expression values, as explained in Figure 1. Both Figures were generated using data from four replicate independent experiments.
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overcomes the immune response to cause chronic infec-
tions that can last for decades in untreated patients.
Paradoxically, H. pylori may have both pro-inflammatory
as well as anti-inflammatory mechanisms. These oppos-
ing forces must operate in such a fashion as to achieve a
delicate balance that involves complex interactions be-
tween bacterial virulence factors and host innate and
adaptive immune system factors.
How does arginase in wild type H. pylori act as an
anti-inflammatory mediator? While the underlying
mechanisms are still not well understood, the depletion
of arginine by this enzyme from the extracellular envir-
onment may be one factor that triggers altered gene ex-
pression in the gastric epithelial cell. Precedence for this
idea comes from prior work showing that arginine de-
pletion leads to altered T cell receptor zeta chain expres-
sion (CD3ζ) [16]. Another possibility is that the products
of arginine hydrolysis, namely, ornithine and urea, could
also be playing a role in altering transcriptional
responses by the gastric epithelial cells. A third possibil-
ity is that the arginase mutant, through disruption of the
bacterial metabolic balance of arginine, ornithine, or
urea levels, could have altered gene transcriptionalprofiles leading to modified expression of other bacterial
virulence factors that interplay with the host immune
system.
A fourth possibility is that the increase in IL-8 produc-
tion induced by the H. pylori rocF- mutant is through
altered spermine produced by the AGS cells. Previous
reports have shown that H. pylori infection induces orni-
thine decarboxylase (ODC) in macrophages [15,18].
ODC degrades L-ornithine into putrescine and this is
later converted into spermidine and finally spermine. Al-
though we did not find differences in the level of mRNA
for the spermine synthase (SMS), we did find that orni-
thine decarboxylase (ODC) and spermidine synthase
mRNA (SRM), two key enzymes in the production of
spermine, were 20% and 41%, respectively, reduced in
the rocF-mutant-infected AGS cells (data not shown). It
has also been shown that spermine can reduce the in-
flammatory response by post-transcriptional inhibition
of the production of pro-inflammatory cytokines, includ-
ing TNFα, IL6, MIP-1α, and MIP-1β [19], and even
though IL-8 was not included in this study, it is possible
that it is regulated by spermine as well. Thus, in the
interaction of wild type H. pylori with AGS cells, sperm-
ine levels may be elevated in the AGS cells, leading to a
Table 1 Ten most up- and 10 most down-regulated genes
in AGS cells in response to the infection with the
different strains of H. pylori
Raw Signal Net Signal*
H. pylori strain H. pylori strain
TargetID NS WT rocF- rocF+ WT rocF- rocF+
IL8 130.5 531.8 4021.7 1276.8 401.3 3891.2 1146.3
S100A3 143.6 298.2 1488.3 463 154.6 1344.7 319.4
KRT17 1115.3 2555.1 11710.4 7149.9 1439.8 10595.1 6034.6
LCP1 214.4 351.2 1585.8 568.8 136.8 1371.4 354.4
SERPINB2 116.2 129.1 547.4 235.8 12.9 431.2 119.6
RND1 113.6 171.3 576 195.7 57.7 462.4 82.1
ACTG2 402.8 417.7 1388.5 723.4 14.9 985.7 320.6
SPOCD1 170.4 250.4 748 321.4 80 577.6 151
RASD1 157.5 192.8 563.6 269.5 35.3 406.1 112
PLAUR 450.2 1714 4856.2 1649.2 1263.8 4406 1199
RPP40 2648 1581.3 591.7 2117.1 −1066.7 −2056.3 −530.9
RRS1 596.6 397.5 148.2 477.9 −199.1 −448.4 −118.7
CABC1 1038.4 698.2 254.1 652.8 −340.2 −784.3 −385.6
ZNF239 591.8 389.4 139.8 409.2 −202.4 −452 −182.6
SLC1A3 1269.7 1028.9 364.7 875.9 −240.8 −905 −393.8
SOX2 652.5 373.5 126.3 389.7 −279 −526.2 −262.8
LOC91461 830.4 527.4 160.9 606.7 −303 −669.5 −223.7
FGD3 654.5 384.4 115 262.7 −270.1 −539.5 −391.8
ATF7IP2 1059 662.3 185.1 665.7 −396.7 −873.9 −393.3
DKK1 5514.2 2808.6 264.6 2722.3 −2705.6 −5249.6 −2791.9
*Net signal is obtained by subtracting the raw value from the values obtained
in H. pylori-infected AGS cells. NS, Non-infected AGS cells.
Figure 3 Infection with the H. pylori 26695 rocF- mutant induces sign
counterparts. Fold induction of genes depicted in Figure 2, performed as
gene and one internal calibrator. * p< 0.0001, as compared to the inductio
average expression± SEM of three independent replicates.
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response. These possibilities await further in depth
analyses.
We performed pair-wise comparison of transcriptome
on the human adenocarcinoma gastric cell line AGS
after infection with 26695 wild type, its isogenic rocF-
knockout mutant, and a rocF- complemented (rocF+) H.
pylori strain, with uninfected AGS cells as a control. The
first observation with the microarray analysis was an
overall increase in the number of genes that participate
in several signaling pathways previously investigated
with H. pylori infection, notably with NFKB and AP-1
activation and mitogen-activated protein kinase (espe-
cially ERKs, JNKs, SAPKs) [20], along with JUN-
mediated signaling. From this activation cascade, the
induction of IL-8 marked the greatest difference between
the rocF- mutant H. pylori versus either the WT or the
rocF+ complemented strain. Our results show a signifi-
cant increase of mRNA and protein levels of IL-8 in
AGS cells infected with the rocF- mutant strain, suggest-
ing that WT bacteria may be able to control the inflam-
matory infiltration of immune cells by controlling the
production of IL-8, which is a potent chemotactic factor
for inflammatory cells, especially neutrophils [21-24].
While many H. pylori factors have been suggested to
stimulate IL-8 expression, including peptidoglycan, LPS,
CagA, VacA, PicB, IceA, urease (and even ammonia)
[25-28], less is known about bacterial factors involved in
suppression of cytokine production, especially in epithe-
lial cells. Mechanisms for immune evasion by H. pylori
have been demonstrated, including the presence of a lessificantly higher levels of IL-8 than its wild type or rocF+
explained in Materials and Methods using GAPDH as housekeeping
n in response to the infection with H. pylori rocF-. Values represent the
Figure 4 The H. pylori rocF- mutant induces more IL-8 and MIP-1β in AGS cells than wild type H. pylori, as determined by Bioplex.
Supernatants from H. pylori infected-AGS cells were collected and used to determine the concentration of IL-8 and MIP-1β (pg/ml) A. Levels of
IL-8; one-way ANOVA p< 0.0001; *p= 0.0001 (rocF- vs NS); #p= 0.0249 (rocF- vs WT); **p= 0.044 (rocF- vs rocF+); B. Levels of MIP-1B; one-way
ANOVA p< 0.0001; *p< 0.0001 (rocF- vs NS); #p< 0.0001 (rocF- vs WT); p= 0.0001 (rocF- vs rocF+). Values in both Figures represent the average
signal ± SEM of four independent replicates.
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fewer studies dealt with reduced host cytokine produc-
tion as an immune suppressive mechanism, including
effects on IL-12 [30-32]. While an increased amount of
cytokines can result in histologically more intense gastri-
tis [33], the limitation of this cytokine induction could
be an advantage to the bacteria so that it can stay under
the radar of the immune system. However, due to the
complexity of the H. pylori-gastric cell interaction, and
the complexity of the lesions induced by the infection, it
is expected that multiple pathways are activated and the
balance of those pathways may determine the presence
or the evolution of the gastric lesions.Figure 5 The rocF mutant of H. pylori induces more IL-8 in AGS cells c
analysis. Please see legend on Figure 4 for IL-8. One-way ANOVA p= 0.000
(rocF- vs rocF+). Values represent the average signal ± SEM of four independEfforts to determine the effect of the infection with H.
pylori rocF- strains in the cellular infiltration of the gastric
mucosa are currently underway. To the best of our know-
ledge, there is only one published work trying to measure
the levels of H. pylori arginase in gastric biopsies of
patients with gastritis and its correlation with disease [34].
That work showed that there is a lot of variability on the
levels of H. pylori arginase in biopsies but the authors
were not able to establish a correlation with the degree of
gastritis. The reason for the increased number of genes
modulated by the rocF- H. pylori, when compared to the
WT and the rocF+ bacteria, is not known; however, our
results, rather than suggesting the existence of H. pyloriompared with wild type H. pylori, as determined by ELISA
2; *p= 0.0003 (rocF- vs NS); #p= 0.045 (rocF- vs WT); **p= 0.0185
ent replicates.
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importance that this enzyme may have in the interaction
of the bacteria with cells in the human gastric mucosa,
and through them, with the immune system. Taken to-
gether our results suggest that H. pylori arginase, by
modulating the production of IL-8 may play a significant
role in the survival of H. pylori in the gastric environment.
By preventing an over-zealous immune response, H. pylori
can achieve its chronicity through the production of argi-
nase and probably other bacterial factors that contribute
to the overall global success of this important and highly-
adapted gastric human pathogen.
Conclusion
Our results highlight the importance of H. pylori argi-
nase in the modulation of inflammatory responses. Since
IL-8 is pivotal for the infiltration of inflammatory cells
into the gastric mucosa, H. pylori arginase may be
involved in reducing the tissue damage associated with
the evolution of the gastric lesions through the modula-
tion of multiple pathways on the gastric epithelial cells.
Methods
Bacterial growth conditions
H. pylori 26695 strains (wild type [WT], rocF- mutant,
and the rocF- mutant chromosomally-complemented
with wild type 26695 rocF- (rocF-26695-MLB0004, here-
after referred to as rocF+) were described previously
[13]. All strains were passaged every 2–3 days on Cam-
pylobacter blood agar (CBA) plates at 37°C with 85%N2,
5% O2, and 10% CO2. Prior to coculture experiments, H.
pylori cells were grown in Ham’s F-12 with heat-
inactivated 1% (v/v) fetal bovine serum (FBS) [35]. H.
pylori growth was monitored by ATP level using Cell
Titer-GloW cell viability assay kit (Promega, NY, USA),
as validated previously [36] and by plating for colony
forming units. Comparable number of viable bacteria
was assured in each experiment.
Tissue culture and co-culture
AGS gastric epithelial cells (ATCC CRL-1739, Rockville,
MD) were maintained in F-12 with heat-inactivated 10%
FBS at 37°C in an atmosphere of 5% CO2. For the
experiments, 1 x 106 AGS cells were seeded into 6-well
plates containing 2 ml fresh F-12 supplemented with 3%
heat-inactivated FBS and cultured for 8 hours. The
media was replaced with 2 ml fresh F-12 containing 3%
heat-inactivated FBS before inoculation of the different
H. pylori at a multiplicity of infection (MOI) of 20. The
infected cells were cultured for additional 16 h after
which the media was collected and stored for ELISA and
BioPlex analyses and the RNA extracted for microarray
and real-time PCR studies.RNA extraction and microarray
To extract the RNA from the AGS cells, coculture
supernatants were removed by aspiration and 1 ml of
TRIZOL (Invitrogen, Carlsbad, CA) was added immedi-
ately to each well. RNA was extracted as recommended
by the manufacturer and was stored at −80°C until fur-
ther use. RNA was dissolved in DNase/RNase-free water,
quantified by NanoDrop (Fisher Scientific) and set at a
concentration of ~1.0 μg/μl. The quality of the RNA was
confirmed by Agilent 2100 Bioanalyzer (Agilent Tech-
nologies, Palo Alto, CA). Each experiment was repeated
four times. Two hundred ng of RNA were used to make
biotinylated cRNA using the Illumina TotalPrep RNA
Amplification Kit (Ambion, Austin, TX), and hybridized
to the Illumina chips for 14 hours at 58°C. After washing
and staining, the arrays were scanned with the BeadAr-
ray Reader (Illumina Inc.) and analyzed with the Geno-
meStudio software (Illumina).Microarray data analysis
After subtracting the background, the samples were nor-
malized assuming a similar distribution of transcript
abundance in all the samples [37]. The net expression
level was obtained by subtracting the intensity obtained
on each treatment (including non-treated cells) from the
intensity at 0 h (prior to seeding the cells into the plate).
Then, the gene levels on the infected cells were com-
pared against the levels on the non-infected cells setting
the p value for the difference at <0.05. Scatter plots com-
paring the non-infected cells against each one of the
other treatments (AGS +WT, AGS+ rocF-, AGS + rocF+)
were used to select only those genes with > 3 fold differ-
ence (up or down-regulated) as compared with the non-
infected cells, and p values less than 0.05 (p < 0.05). In
addition, the Log10 of the ratio between the normalized
intensity in the infected cells and the normalized inten-
sity in the non-infected cells was determined and used
to generate heat maps.Quantitative real-time PCR
For real-time PCR (qPCR), total RNA extracts were
DNase treated and reverse-transcribed with SuperScrip-
tase III (Invitrogen) with random hexamers. TaqMan
pre-designed arrays were used to check the levels of
mRNA expression of IL-8, using cyclophilin A as house-
keeping gene, and following the vendor’s recommenda-
tions (Applied Biosystems, Foster City, CA). The 5 μl
reaction was subjected to two minutes at 50°C, 10 min-
utes at 95°C and finally 40 cycles at 95°C for 15 seconds
and 60°C for one minute in a 7900HT real-time PCR
machine (Applied Biosystems). The delta Ct’s (ΔCt and
ΔΔCt) and fold induction of IL-8 were determined using
an internal control as calibrator.
Kim et al. BMC Microbiology 2012, 12:175 Page 8 of 9
http://www.biomedcentral.com/1471-2180/12/175BioPlex and enzyme-linked immunosorbent essay (ELISA)
Culture supernatants were collected at indicated time
points and clarified of bacteria and host cells by centri-
fugation (3,000 x g for 5 min and then 16,000 x g for
10 min, 4°C). Manufacturer’s manuals were followed for
BioPlex (Bio-Rad, Inc) and human IL-8 ELISA assay (BD
OptEIATM, BD Bioscience). For Bio-Plex analysis, 2 μl of
anti-cytokine conjugated beads were added to each well,
followed by diluted culture supernatants. After 30 min
incubation, samples were washed three times with Bio-
Plex wash buffer, and then 25 μl of detection antibody
solution was added and incubated for another 30 min.
Streptavidin-phycoerythrin (1X; 50 μl) was added to
each well and then washed. For hIL-8 ELISA, duplicate
measurements were done for four separate experiments.
Samples were read at 450 nm on an ELISA reader (Bio-
Rad), of which lowest detection limit was 0.8 pg/ml (BD
OptEIATM, BD Bioscience).
Functional analysis and network generation
Online computational tools of Metacore (Thomson Reu-
ters, Philadelphia, PA) were used to identify annotated
networks of interacting genes, pathways and associated
biological functions among genes profiled from the
microarray analysis, using more than 700 canonical
maps and pathways which are continuously being
updated (www.genego.com). The networks generated
were ranked and built according to G-scores and p
values.
Statistical analysis
All data in each experiment of ELISA and real time PCR
are presented as mean ± SEM of three or four different
experiments. To check for any difference between the
several treatments we did a one-way ANOVA analysis.
To determine differences between specific treatments we
did a two-tailed unpaired t-test.
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